TYNDALL CAPITAL PARTNERS L P

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Cyclerion Therapeutics, Inc. 13G/A Amendment 3
CYCN · 23255M204
4.8% 8/14/2025
Event 6/30/2025
Cyclerion Therapeutics, Inc. 13G/A Amendment 2
CYCN · 23255M204
5.1% 5/15/2025
Event 3/31/2025